Development study details a digital shared decision-making aid for glioblastoma patients, highlighting the integration of patient-reported outcomes like cognitive function and quality of life.
Introduction Facilitating shared decision-making (SDM) and incorporating patient decision aids are recommended by the National Institute for Health and Care Excellence (NICE). However, there is a lack of SDM aids for the specific treatment of high-grade glioma patients. The objective of this study was to describe the design and development process of a digital SDM aid for glioblastoma patients. Methods Following the International Patient Decision Aid Standards (IPDAS), the aid was developed through an iterative process with multi-disciplinary researchers, patient advocates, and a private tech company. The content of the SDM aid was developed by incorporating a prior study’s results, which highlighted several important health outcomes from brain tumor patients’ perspectives. Results The following components were considered when creating the SDM aid: patient feedback on important health outcomes (such as quality of life, maintaining cognitive function, survival rates, and post-operative care), delivery of information on glioblastoma and different treatment options, user engagement, accessibility, and inclusive communication. Conclusion A digital SDM aid was developed to support an SDM intervention for patients with glioblastoma. In a future study, we will test the effectiveness and determine the impact of the developed aid on facilitating the SDM process and health outcomes for patients with glioblastoma.
No takes yet. Share an insight, caveat, or question.
Hughes et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: